Pro- and antiinflammatory cytokines in steatohepatitis: what profile in moderate obesity with diabetes? / Marcadores inflamatórios sistêmicos em pacientes com doença hepática gordurosa não alcoólica (DHGNA)

AUTOR(ES)

Fabiola Rabelo

DATA DE PUBLICAÇÃO

2010

RESUMO

Background: Fatty liver disease is a problem of obesity in the morbid modality and even more so in nonbariatric candidates, who rely on clinical treatment only. TNF- has been frequently measured in steatohepatitis (NASH) with or without diabetes, but less in known about IL-6 and IL-10. Methods: Moderately obese patients (n=80) with histologically proven Steatosis (n=29) and NASH (n=51) were recruited. Serum levels of cytokines were documented along with clinical information. The aim was to identify the correlates of such biomolecules in a stable population.Results: Diabetes tended to be more associated with NASH (52.5% vs 41.4%, P=0.015), with no difference of age, gender or BMI regarding steatosis . For the entire population cytokine changes were not significant., including TNF- and IL-6. In diabetics only, all markers tended to diminish with NASH, especially IL-10 (P= 0.000). IL-10 correlated with HOMA index (P=0.000) and other variables of glucose homeostasis in diabetes, thus representing a major marker of the disease.Conclusions: 1)Generally inconsistent changes in pro- and antiinflammatory cytokines occurred when NASH was globally compared to steatosis. 2) In contrast, downregulation of IL-6 and IL-10 was perceived in diabetics with NASH. 3) Arterial hypertension did not play a role in these circumstances. 4) IL-10 maintained strong correlations with glucose metabolism indices. 5) TNF- could not be incriminated for progressive liver damage, as values failed to increase in NASH. 6) Investigations of IL-10 and other counterregulatory cytokines are lacking in this context and deserve further studies.

ASSUNTO(S)

citocinas cytokines fatty liver biological markers fígado gorduroso diabetes mellitus diabetes mellitus marcadores biológicos

Documentos Relacionados

• Síndrome metabólica e Doença Hepática Gordurosa Não Alcoólica (DHGNA)
• RELAÇÃO ENTRE HÁBITOS DE VIDA E DOENÇAS METABÓLICAS EM COMUNIDADES COM BASE NA DOENÇA HEPÁTICA GORDUROSA NÃO ALCOÓLICA (DHGNA) DIAGNOSTICADA POR ULTRASSOM
• Hiperferritinemia em pacientes com doença hepática gordurosa não alcoólica
• Acurácia diagnóstica de um escore de ultrassonografia hepática não invasivo para doença hepática gordurosa não alcoólica (DHGNA) no Estudo Longitudinal de Saúde do Adulto (ELSA-Brasil)
• Exenatide melhora o diabetes tipo 2 de ocorrência concomitante com doença hepática gordurosa não alcoólica